跳至主要内容
临床试验/NCT03964831
NCT03964831Withheld不适用

[Trial of device that is not approved or cleared by the U.S. FDA]

[Redacted]2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年5月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Withheld
发起方
入组人数
40
试验地点
2
主要终点
Qualitative Image assessment

研究概览

简要总结

The study evaluates image quality between two devices.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female subjects 22 years of age or older who have full legal capacity to volunteer on the date the informed consent is signed;
  • Subjects who can follow the instructions by the clinical staff at the clinical site,
  • Subjects who agree to participate in the study;
  • Subjects diagnosed with retinal pathology. Example of pathologies may include but are not limited to Age-related Macular Degeneration, Diabetic Macular Edema, Diabetic Retinopathy, Macular Hole, Epiretinal Membrane, Central Serous Retinopathy, and others as confirmed by the investigator;

排除标准

  • Subjects unable to tolerate ophthalmic imaging;
  • Subjects with ocular media not sufficiently clear to obtain acceptable images;

研究组 & 干预措施

Ultra widefield image capture

Other

干预措施: P200TxE (Device)

Ultra widefield image capture

Other

干预措施: P200DTx (Device)

结局指标

主要结局

Qualitative Image assessment

时间窗: 6 months

Results from a qualitative assessment of the clinical utility and image quality of the images from both devices will be assessed from a clinician questionnaire and three independent masked and qualified graders using a four point scale (0-3).

Safety Assessment from Adverse Events

时间窗: 6 months

Analysis of safety will be assessed through adverse events reported by the site and documented on each subject's case report form.

次要结局

未报告次要终点

研究者

发起方
[Redacted]

研究点 (2)

Loading locations...

相似试验